Erlonat 150MG ( ERLOTINIB 150 MG)

Product Description

ERLOTINIB 25MG,100MG,150MG.....

PRODUCT OF NATCO COMPANY - ERLONAT

Erlonat-Erlotinib
Erlonat belongs to a class of medications called Kinase inhibitors and contains erlotinib. It is used for the treatment of non-small cell lung cancer and in combination with Gemcitabine, is used for the treatment of pancreatic cancer which spreads to adjacent tissues of the body. The action mechanism of the medicine is as follows:
Functions by blocking the action of an abnormal protein to slow down the growth of cancer cells

Supplied as:
Available in 25 mg, 100 mg & 150 mg tablets

Dosage:
Usually 150 mg tablet is administered, at least an hour before or two hours after the ingestion of food, for curing pancreatic non-small cell lung cancer. Erlonat is usually given as 100 mg tablets, at least an hour before or two hours after the intake of food, for curing of pancreatic cancer, in combination with gemcitabine.

Overdose
Symptoms of overdose may include diarrhea and rash

Precautions and warnings

1. The medicine should not be taken without consulting the doctor if the patient has liver disease, lung or breathing problems (other than lung cancer).
2. Do not take , or products containing , unless prescribed by the doctor Patient must take Erlonat at substantial time gap, if antacids are also being taken If the patient is allergic to the medicine or any of its constituents, then intake is not suggestible
3. Erlonat consumption should avoided if the patient is pregnant or breast feeding the child. Doctor consultation suggested for use of birth control during treatment with Erlonat. It is not yet established whether Erlonat passes into breast milk or not.

Drug Interactions
The following drugs may interact with Erlonat:

• Atazanavir
• Nelfinavir
• Indinavir
• Saquinavir
• Ritonavir
• Rifampin
• Rifabutin
• Rifapentine
• Clarithromycin
• Nefazodone
• Telithromycin
• Troleandomycin
• Carbamazepine
• Phenytoin
• Ketoconazole
• Itraconazole
• VoriconazoleSt. John's Wort

Side effects of the medicine are as follows:

• Breathing
• Closing of the throat
• Swelling of the lips, tongue, face or hives
• Shortness of breath
• Increased coughing
• Fever and chest pain
• Severe or persistent nausea
• Vomiting and loss of appetite
• Diarrhea
• Eye pain or irritation
• Skin rash, dryness, itching and acne
• Weakness
• Blistering and peeling
• Dry or cracked skin
• Itching, tenderness or burning of the skin
• Growth of eyelashes on the inside of the eyelid
• Unusual bruising or bleeding

Note: Erlonat is a prescription drug and should be used under proper medical guidance and advice. Do not share the medicine with others, since they may be suffering from a problem that is not effectively treated by this drug.